Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma

The isolation from brain tumors of tumor mesenchymal stem-like cells (tMSLCs) suggests that these cells play a role in creating a microenvironment for tumor initiation and progression. The clinical characteristics of patients with primary glioblastoma (pGBM) positive for tMSLCs have not been determi...

Full description

Saved in:
Bibliographic Details
Main Authors: Seon-Jin Yoon, Jin-Kyoung Shim, Jong Hee Chang, Ju Hyung Moon, Tae-Hoon Roh, Kyoung Su Sung, Ji-Hyun Lee, Eui-Hyun Kim, Sun Ho Kim, Yong-Kil Hong, Su-Jae Lee, Yong-Min Huh, Seok-Gu Kang
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/6756983
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552374046031872
author Seon-Jin Yoon
Jin-Kyoung Shim
Jong Hee Chang
Ju Hyung Moon
Tae-Hoon Roh
Kyoung Su Sung
Ji-Hyun Lee
Eui-Hyun Kim
Sun Ho Kim
Yong-Kil Hong
Su-Jae Lee
Yong-Min Huh
Seok-Gu Kang
author_facet Seon-Jin Yoon
Jin-Kyoung Shim
Jong Hee Chang
Ju Hyung Moon
Tae-Hoon Roh
Kyoung Su Sung
Ji-Hyun Lee
Eui-Hyun Kim
Sun Ho Kim
Yong-Kil Hong
Su-Jae Lee
Yong-Min Huh
Seok-Gu Kang
author_sort Seon-Jin Yoon
collection DOAJ
description The isolation from brain tumors of tumor mesenchymal stem-like cells (tMSLCs) suggests that these cells play a role in creating a microenvironment for tumor initiation and progression. The clinical characteristics of patients with primary glioblastoma (pGBM) positive for tMSLCs have not been determined. This study analyzed samples from 82 patients with pGBM who had undergone tumor removal, pathological diagnosis, and isolation of tMSLC from April 2009 to October 2014. Survival, extent of resection, molecular markers, and tMSLC culture results were statistically evaluated. Median overall survival was 18.6 months, 15.0 months in tMSLC-positive patients and 29.5 months in tMSLC-negative patients (P=0.014). Multivariate cox regression model showed isolation of tMSLC (OR = 2.5, 95% CI = 1.1~5.6, P=0.021) showed poor outcome while larger extent of resection (OR = 0.5, 95% CI = 0.2~0.8, P=0.011) has association with better outcome. The presence of tMSLCs isolated from the specimen of pGBM is associated with the survival of patient.
format Article
id doaj-art-97aaecebcecf4072bb801ddad7d61f56
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-97aaecebcecf4072bb801ddad7d61f562025-02-03T05:58:48ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/67569836756983Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary GlioblastomaSeon-Jin Yoon0Jin-Kyoung Shim1Jong Hee Chang2Ju Hyung Moon3Tae-Hoon Roh4Kyoung Su Sung5Ji-Hyun Lee6Eui-Hyun Kim7Sun Ho Kim8Yong-Kil Hong9Su-Jae Lee10Yong-Min Huh11Seok-Gu Kang12Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Republic of KoreaDepartment of Life Science, Hanyang University, 17 Haendang-dong, Seongdong-gu, Seoul 133-791, Republic of KoreaDepartment of Radiology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of KoreaThe isolation from brain tumors of tumor mesenchymal stem-like cells (tMSLCs) suggests that these cells play a role in creating a microenvironment for tumor initiation and progression. The clinical characteristics of patients with primary glioblastoma (pGBM) positive for tMSLCs have not been determined. This study analyzed samples from 82 patients with pGBM who had undergone tumor removal, pathological diagnosis, and isolation of tMSLC from April 2009 to October 2014. Survival, extent of resection, molecular markers, and tMSLC culture results were statistically evaluated. Median overall survival was 18.6 months, 15.0 months in tMSLC-positive patients and 29.5 months in tMSLC-negative patients (P=0.014). Multivariate cox regression model showed isolation of tMSLC (OR = 2.5, 95% CI = 1.1~5.6, P=0.021) showed poor outcome while larger extent of resection (OR = 0.5, 95% CI = 0.2~0.8, P=0.011) has association with better outcome. The presence of tMSLCs isolated from the specimen of pGBM is associated with the survival of patient.http://dx.doi.org/10.1155/2016/6756983
spellingShingle Seon-Jin Yoon
Jin-Kyoung Shim
Jong Hee Chang
Ju Hyung Moon
Tae-Hoon Roh
Kyoung Su Sung
Ji-Hyun Lee
Eui-Hyun Kim
Sun Ho Kim
Yong-Kil Hong
Su-Jae Lee
Yong-Min Huh
Seok-Gu Kang
Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
Stem Cells International
title Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
title_full Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
title_fullStr Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
title_full_unstemmed Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
title_short Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
title_sort tumor mesenchymal stem like cell as a prognostic marker in primary glioblastoma
url http://dx.doi.org/10.1155/2016/6756983
work_keys_str_mv AT seonjinyoon tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT jinkyoungshim tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT jongheechang tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT juhyungmoon tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT taehoonroh tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT kyoungsusung tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT jihyunlee tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT euihyunkim tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT sunhokim tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT yongkilhong tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT sujaelee tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT yongminhuh tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma
AT seokgukang tumormesenchymalstemlikecellasaprognosticmarkerinprimaryglioblastoma